Interleukin-1 Antagonist May Curb HPA Activation in Obese Individuals Interleukin-1 Antagonist May Curb HPA Activation in Obese Individuals

Blocking interleukin-1 (IL-1) may reduce hypothalamic-pituitary-adrenal (HPA)-axis activation in obese individuals with metabolic syndrome, according to new research.Reuters Health Information

Source: Medscape Medical News Headlines - March 13, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news